Moxidectin
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101670This classification denotes an antiparasitic agent with the molecular formula C37H53NO8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NGU5H31YO9, chemically known as milbemycin b, 5-o-demethyl-28-deoxy-25-((1e)-1,3-dimethyl-1-butenyl)-6,28-epoxy-23-(methoxyimino)-, (6r,23e,25s)- but generally known as moxidectin, which bears US NIH Compound Identifier 9571036. European Medicines Agency schedules Moxidectin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09085MIG. The term MOXIDECTIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). MOXIDECTIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, MOXIDECTIN remains the US FDA Preferred Term for this commodity. Moxidectin bears US NLM identifiers UMLS ID C0163557 and NCI Concept Code C73264. SMILES: O1C2(OC(C(C(=N\OC)\C2)C)/C(=C/C(C)C)C)CC2OC(=O)C3C4(O)C(OCC4=CC=CC(CC(=CCC1C2)C)C)C(O)C(=C3)C.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.